Cipla 517 50 MG (Cyclophosphamide 50 mg)
Pill with imprint Cipla 517 50 MG is Blue & White, Capsule-shape and has been identified as Cyclophosphamide 50 mg. It is supplied by Cipla USA Inc..
Cyclophosphamide is used in the treatment of acute lymphocytic leukemia; breast cancer; acute nonlymphocytic leukemia; cancer; chronic lymphocytic leukemia and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Cyclophosphamide 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Cipla 517 50 MG
More about cyclophosphamide
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- 12 Reviews
- Drug class: alkylating agents
- Cyclophosphamide oral and injection
- Cyclophosphamide Capsules
- Cyclophosphamide Injection
- Cyclophosphamide Tablets
- Cyclophosphamide Oral, Intravenous (Advanced Reading)
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.